
-
Iconic Bayeux Tapestry to be loaned to Britain: French president
-
Lyles to make 200m return against Tebogo in Monaco
-
UK post office scandal may have caused 13 suicides: inquiry
-
Some Europeans still travel to Iran, ignoring dire warnings
-
ICC seeks arrest of Taliban leaders over persecution of women
-
Stocks mark time as Trump postpones tariffs deadline
-
India expect England's Archer to pose 'challenge'
-
Springboks make 11 changes for Italy Test
-
Liverpool return to training in wake of Jota death
-
France's Marseille airport says closing due to nearby wildfire
-
France's Macron kicks off 'historic' UK state visit
-
Aussie prop Tupou hopes Racing move will bring smile back
-
Speeding likely cause of Diogo Jota car crash: police
-
Bulgaria becomes 21st member to adopt euro after EU green light
-
'Free culture': Slovak gunman defends Fico shooting as trial begins
-
Rome to host Ukraine recovery conference as US support falters
-
Qatar says 'we will need time' for Gaza ceasefire
-
Alcaraz faces Norrie test at Wimbledon, Sabalenka eyes semi-finals
-
Forest fire blazes in southern France
-
Indian villagers beat five to death for 'witchcraft'
-
Gaza ceasefire talks resume as Trump upbeat on deal
-
Stocks rise as Trump delays tariffs deadline
-
Acropolis shuts, outdoor work halted as heatwave scorches Greece
-
Newcastle agree £55m fee for Forest's Elanga - reports
-
German exports to US tumble as Berlin urges quick trade deal
-
Tottenham sign Japan defender Takai
-
Cambodian garment workers fret Trump's new tariff threat
-
Israel-Hamas ceasefire negotiations resume as Trump pushes for deal
-
Trial of Slovak gunman who shot PM begins
-
Wallabies' Lolesio faces long rehab after surgery
-
Lions not invincible says former All Blacks coach Foster
-
Markets rise as Trump sends tariff letters, delays deadline
-
Australia-born Lion Hansen faces 'pinch-me' moment against old team
-
Mitre by mitre: N. Macedonian nuns craft priceless holy headwear
-
S.Leone islanders despair as rising ocean threatens survival
-
Bulgaria to get final green light to adopt euro in 2026
-
Major garment producer Bangladesh seeks deal after 35% US tariff
-
France's Macron kicks off pomp-filled UK state visit
-
Mbappe and PSG set for Club World Cup reunion as Real Madrid eye final
-
US to send 'more weapons' to Ukraine: Trump
-
Most markets rise as Trump sends tariff letters, delays deadline
-
Slovak gunman who shot PM to go on trial
-
As heatwaves intensify, Morocco ups effort to warn residents
-
All Blacks captain Scott Barrett out for rest of France series
-
AI video becomes more convincing, rattling creative industry
-
Trump says new tariff deadline 'not 100 percent firm'
-
Trump hosts Netanyahu in push for Gaza deal
-
Alpha males are rare among our fellow primates: scientists
-
At least 10 dead in Kenya during protests after heavy police deployment
-
Battery Asset Management Summit Launches in Australia to Power the Nation's Energy Revolution

CBDL Announces Strategic Rollout on Vibe Performance Network, Elevating 8000MG Pain Cream to National Streaming Audiences
CBD Life Sciences Inc. (OTC:CBDL) expands its digital advertising arsenal through the Vibe Performance Network, positioning its flagship 8000MG Pain Cream in front of millions of engaged, wellness-focused viewers - unlocking massive revenue potential and long-term shareholder value in the booming CBD market.
SCOTTSDALE, ARIZONA / ACCESS Newswire / July 8, 2025 / CBD Life Sciences Inc. (OTC:CBDL), parent company of CBD Vault, is thrilled to announce a transformational leap in its national marketing strategy through integration with Vibe, a cutting-edge self-serve streaming TV advertising platform. This strategic move empowers CBDL to deliver targeted, data-driven campaigns across top-tier streaming platforms including Hulu, ESPN+, Roku, Discovery+, Tubi, and dozens of other premium outlets.
As part of this rollout, CBDL will begin aggressively marketing its new 8000MG Pain Relief Cream - its most potent and in-demand product to date. Designed for athletes, chronic pain sufferers, and everyday individuals seeking fast, long-lasting relief, the 8000MG Pain Cream delivers unparalleled results - and now, it will reach a national audience with unmatched precision.
"This initiative represents one of the most important and scalable steps forward in CBDL's history," said Lisa Nelson, President & CEO of CBDL. "With Vibe, we're not just buying ad space - we're owning the channel to our core audience. This technology allows us to place the right product in front of the right person at the right time. That means greater efficiency, greater visibility, and greater returns."
The Vibe Advantage: Why This is a Major Inflection Point for CBDL
CBDL's integration with the Vibe Performance Network gives the company unprecedented access to millions of health-conscious consumers across the U.S., including targeted audiences based on:
Demographics (age, gender, income)
Behavioral habits and content interests
Zip-code level geographic targeting
Engagement with wellness, recovery, fitness, and CBD-related content
Unlike traditional TV or social media ads, Vibe campaigns are performance-optimized - allowing for real-time analytics, creative testing, and dynamic budget scaling, all while keeping advertising costs significantly lower than legacy platforms.
Projected Revenue Impact and Market Positioning
With this expanded visibility, CBDL is now positioned to unlock significant recurring revenue across both direct-to-consumer and wholesale channels. Based on historical customer conversion data and industry benchmarks, the 8000MG Pain Cream campaign alone could drive a projected 7-figure boost in annual revenue, with the potential to scale beyond as CBD Vault's product line continues to grow.
This launch directly supports the company's mission of becoming a nationally recognized leader in natural wellness solutions, while laying the groundwork for future product launches using the same Vibe infrastructure.
The global CBD market is forecasted to exceed $22 billion by 2030, and topical CBD products - like pain creams - are expected to see the highest CAGR within the industry at over 32.1% annually, according to Grand View Research.
CBDL's powerful combination of product efficacy, consumer trust, and now digital ad precision, gives the company a major competitive edge as it scales nationwide.
Investor Significance
For current and prospective investors, this strategic deployment represents a material turning point in how the company markets, sells, and scales. By implementing a scalable, intelligent advertising ecosystem, CBDL is no longer reliant on outdated, inefficient marketing tactics - instead embracing the same programmatic tools used by Fortune 500 brands, tailored for the cannabis and wellness space.
In essence, CBDL now controls its own national media pipeline, giving the company the ability to:
Increase customer acquisition at lower costs
Expand brand awareness across multiple demographics
Support higher margins and longer customer lifetime value
Launch future products into an already-primed national audience
"This is more than just a campaign - it's infrastructure," added Nelson. "It's a system that can be used again and again to take new products to market, drive sales, and fuel consistent growth. It's a future-proof marketing engine."
Vibe Platform Website : https://www.vibe.co/

About CBD Life Sciences Inc. (CBDL)
CBD Life Sciences Inc. is an innovative health and wellness company committed to the research, development, and distribution of premium cannabidiol (CBD) products through its core brand, CBD Vault. From topicals and tinctures to wellness beverages and skincare solutions, CBDL is building a portfolio of products designed for maximum efficacy, transparency, and consumer trust.
Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: [email protected]
Stay Connected & Be the First to Try Our New Functional Mushroom Products!
Mushroom Madness Instagram: https://www.instagram.com/mushroom.madnessaz
Mushroom Madness Website: https://www.mushroommadness.shop
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
Contact Information
Lisa Nelson
CEO
[email protected]
4802091720
SOURCE: CBD Life Sciences, Inc.
View the original press release on ACCESS Newswire
P.Costa--AMWN